Skip to main content

Neuronet Meeting Newsroom

Conference Coverage
02/03/2025
Hannah Musick
Gain insights on navigating the future of neurological therapies from industry experts at the 2025 NeuroNet Pro Annual Summit.
Gain insights on navigating the future of neurological therapies from industry experts at the 2025 NeuroNet Pro Annual Summit.
Gain insights on navigating the...
02/03/2025
First Report Managed Care
Conference Coverage
01/31/2025
Hannah Musick
Panelists at the 2025 NeuroNet Pro Annual Summit discussed chronic care management, teleconsultations, and operational efficiency tools to support overwhelmed private practice neurologists.
Panelists at the 2025 NeuroNet Pro Annual Summit discussed chronic care management, teleconsultations, and operational efficiency tools to support overwhelmed private practice neurologists.
Panelists at the 2025 NeuroNet...
01/31/2025
First Report Managed Care
Conference Coverage
01/31/2025
Hannah Musick
A presentation at 2025 NeuroNet Pro Annual Summit outlines the current challenges and potential benefits of integrating imaging in-house for neurologists.
A presentation at 2025 NeuroNet Pro Annual Summit outlines the current challenges and potential benefits of integrating imaging in-house for neurologists.
A presentation at 2025 NeuroNet...
01/31/2025
First Report Managed Care
Conference Coverage
01/31/2025
Hannah Musick
Learn how the future of neurological care, marked by increasing patient demand, physician burnout, and shifts in treatment approaches, presents challenges and opportunities for neurologists to improve patient outcomes and create a more...
Learn how the future of neurological care, marked by increasing patient demand, physician burnout, and shifts in treatment approaches, presents challenges and opportunities for neurologists to improve patient outcomes and create a more...
Learn how the future of...
01/31/2025
First Report Managed Care

Conference Coverage
02/03/2025
Hannah Musick
Gain insights on navigating the future of neurological therapies from industry experts at the 2025 NeuroNet Pro Annual Summit.
Gain insights on navigating the future of neurological therapies from industry experts at the 2025 NeuroNet Pro Annual Summit.
Gain insights on navigating the...
02/03/2025
First Report Managed Care
Conference Coverage
01/31/2025
Hannah Musick
Panelists at the 2025 NeuroNet Pro Annual Summit discussed chronic care management, teleconsultations, and operational efficiency tools to support overwhelmed private practice neurologists.
Panelists at the 2025 NeuroNet Pro Annual Summit discussed chronic care management, teleconsultations, and operational efficiency tools to support overwhelmed private practice neurologists.
Panelists at the 2025 NeuroNet...
01/31/2025
First Report Managed Care
Conference Coverage
01/31/2025
Hannah Musick
A presentation at 2025 NeuroNet Pro Annual Summit outlines the current challenges and potential benefits of integrating imaging in-house for neurologists.
A presentation at 2025 NeuroNet Pro Annual Summit outlines the current challenges and potential benefits of integrating imaging in-house for neurologists.
A presentation at 2025 NeuroNet...
01/31/2025
First Report Managed Care
Conference Coverage
01/31/2025
Hannah Musick
Learn how the future of neurological care, marked by increasing patient demand, physician burnout, and shifts in treatment approaches, presents challenges and opportunities for neurologists to improve patient outcomes and create a more...
Learn how the future of neurological care, marked by increasing patient demand, physician burnout, and shifts in treatment approaches, presents challenges and opportunities for neurologists to improve patient outcomes and create a more...
Learn how the future of...
01/31/2025
First Report Managed Care
Usmani Headshot
Conference Coverage
09/08/2025
Saad Z. Usmani, MD, FACP
Dr Saad Usmani, chief of the myeloma service at Memorial Sloan Kettering Cancer Center, explores the evolving debate on early intervention for high-risk smoldering multiple myeloma, highlighting pivotal trial data and its potential to reshape...
Dr Saad Usmani, chief of the myeloma service at Memorial Sloan Kettering Cancer Center, explores the evolving debate on early intervention for high-risk smoldering multiple myeloma, highlighting pivotal trial data and its potential to reshape...
Dr Saad Usmani, chief of the...
09/08/2025
First Report Managed Care
Martin
Conference Coverage
09/03/2025
Thomas G. Martin, III, MD
Dr Thomas Martin previews his SOHO 2025 session and explores the pressing next questions in multiple myeloma, including when to treat smoldering disease, how to better define and manage high-risk patients, and how innovations like bispecifics...
Dr Thomas Martin previews his SOHO 2025 session and explores the pressing next questions in multiple myeloma, including when to treat smoldering disease, how to better define and manage high-risk patients, and how innovations like bispecifics...
Dr Thomas Martin previews his...
09/03/2025
First Report Managed Care
Raje Headshot
Conference Coverage
09/02/2025
Noopur S. Raje, MD
At SOHO 2025, Dr Noopur Raje will present a cutting-edge overview of CAR T-cell therapy in multiple myeloma, highlighting long-term efficacy data, novel targets like GPRC5D, emerging dual-targeting and in vivo CAR strategies, and the evolving...
At SOHO 2025, Dr Noopur Raje will present a cutting-edge overview of CAR T-cell therapy in multiple myeloma, highlighting long-term efficacy data, novel targets like GPRC5D, emerging dual-targeting and in vivo CAR strategies, and the evolving...
At SOHO 2025, Dr Noopur Raje...
09/02/2025
First Report Managed Care
Hilger Headshot
Conference Coverage
06/26/2025
Chris Hilger
An expert shares a pragmatic approach to tech adoption in infusion centers—starting with simple, high-impact data tools like Power Query that deliver return on investment without the overhead of complex artificial intelligence (AI) systems.
An expert shares a pragmatic approach to tech adoption in infusion centers—starting with simple, high-impact data tools like Power Query that deliver return on investment without the overhead of complex artificial intelligence (AI) systems.
An expert shares a pragmatic...
06/26/2025
First Report Managed Care
Noonan Headshot
Conference Coverage
06/26/2025
Learn how a groundbreaking, patient-directed grant structure is improving access and autonomy for individuals with diverse health care needs.
Learn how a groundbreaking, patient-directed grant structure is improving access and autonomy for individuals with diverse health care needs.
Learn how a groundbreaking,...
06/26/2025
First Report Managed Care
McIntyre
Conference Coverage
06/25/2025
Pamela McIntyre, MSN, RN
As oncology care shifts toward community-based settings, this interview explores how ambulatory infusion centers can prepare clinically and operationally to safely deliver biologic therapies for cancer patients.
As oncology care shifts toward community-based settings, this interview explores how ambulatory infusion centers can prepare clinically and operationally to safely deliver biologic therapies for cancer patients.
As oncology care shifts toward...
06/25/2025
First Report Managed Care
Shackleton
Conference Coverage
06/25/2025
Explore how state policies on copay accumulators, PBMs, and step therapy are shaping the future of infusion care—and what you can do about it.
Explore how state policies on copay accumulators, PBMs, and step therapy are shaping the future of infusion care—and what you can do about it.
Explore how state policies on...
06/25/2025
First Report Managed Care
Conference Coverage
06/03/2025
Hannah Musick
Real-world data show ofatumumab significantly reduces relapse rates compared to ocrelizumab in patients with relapsing multiple sclerosis, including those who are treatment-naïve.
Real-world data show ofatumumab significantly reduces relapse rates compared to ocrelizumab in patients with relapsing multiple sclerosis, including those who are treatment-naïve.
Real-world data show ofatumumab...
06/03/2025
First Report Managed Care
Conference Coverage
06/03/2025
Juliet Gallagher
As patient portals become increasingly central to chronic disease management, new research presented at CMSC 2025 offers insights into how people living with multiple sclerosis (MS) use these tools—and how their adoption may intersect with...
As patient portals become increasingly central to chronic disease management, new research presented at CMSC 2025 offers insights into how people living with multiple sclerosis (MS) use these tools—and how their adoption may intersect with...
As patient portals become...
06/03/2025
First Report Managed Care
Conference Coverage
06/02/2025
Juliet Gallagher
At CMSC 2025, researchers presented 11-year follow-up data confirming the long-term efficacy and safety of ocrelizumab (OCR) in people with multiple sclerosis (pwMS), including both relapsing (pwRMS) and primary progressive (pwPPMS) forms of...
At CMSC 2025, researchers presented 11-year follow-up data confirming the long-term efficacy and safety of ocrelizumab (OCR) in people with multiple sclerosis (pwMS), including both relapsing (pwRMS) and primary progressive (pwPPMS) forms of...
At CMSC 2025, researchers...
06/02/2025
First Report Managed Care